(Q42616171)

3 November 2017

Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies (English)

1 reference

left ventricular hypertrophy

3 November 2017

0 references

1 reference

inferred from title

author

Julio Gallego-Delgado

object named as

Julio Gallego-Delgado

1

0 references

author name string

Susan B Connolly

2

1 reference

3 November 2017

Alberto Lázaro

3

1 reference

3 November 2017

Denise Sadlier

4

1 reference

3 November 2017

Niamh E Kieran

5

1 reference

3 November 2017

Declan D Sugrue

6

1 reference

3 November 2017

Peter Doran

7

1 reference

3 November 2017

Hugh R Brady

8

1 reference

3 November 2017

Julio Osende

9

1 reference

3 November 2017

Jesus Egido

10

1 reference

3 November 2017

language of work or name

1 reference

27 March 2009

1 reference

3 November 2017

Hypertension Research

1 reference

3 November 2017

32

1 reference

3 November 2017

347-357

1 reference

3 November 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2009.27

3 November 2017

0 references

cites work

Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Effects of early and late chronic pressure overload on extracellular matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Role of the renin-angiotensin system in vascular diseases: expanding the field.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Correspondence analysis applied to microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Mitochondrial proteins in hypertrophy and atrophy: a transcript analysis in rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Glycolysis and pyruvate oxidation in cardiac hypertrophy--why so unbalanced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Energy metabolism in the hypertrophied heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

gp130 plays a critical role in pressure overload-induced cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Akt/protein kinase B promotes organ growth in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Transgenic myocardial overexpression of fibroblast growth factor-1 increases coronary artery density and branching.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Gene expression changes associated with fibronectin-induced cardiac myocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

TGF-beta signaling and the fibrotic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

TGF-beta1 and angiotensin networking in cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Angiotensin II-stimulated collagen synthesis in aortic adventitial fibroblasts is mediated by connective tissue growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Angiotensin II Type 1 Receptor Blocker Attenuates Myocardial Remodeling and Preserves Diastolic Function in Diabatic Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Txnip balances metabolic and growth signaling via PTEN disulfide reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Long-term blood pressure control prevents oxidative renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Cardiac hypertrophy: the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

A specific role of AGS3 in the surface expression of plasma membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Chronic inhibition of Rho kinase blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension-induced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Molecular regulation of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Activation of the Cbl insulin signaling pathway in cardiac muscle; dysregulation in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Pathogenesis of dilated cardiomyopathy: molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Small GTPase Tc10 and its homologue RhoT induce N-WASP-mediated long process formation and neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

7 January 2021

The prognosis of heart failure in the general population: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

7 January 2021

Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

7 January 2021

Mitochondrial energy metabolism in heart failure: a question of balance

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

7 January 2021

Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

7 January 2021

Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

7 January 2021

Increased accumulation of acidic fibroblast growth factor in left ventricular myocytes of patients with idiopathic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

7 January 2021

Connective tissue growth factor induces cardiac hypertrophy through Akt signaling

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

7 January 2021

Gene expression profiling of alpha(1b)-adrenergic receptor-induced cardiac hypertrophy by oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

7 January 2021

Bradykinin blocks angiotensin II-induced hypertrophy in the presence of endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

7 January 2021

Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.27

7 January 2021

Identifiers

DOI

10.1038/HR.2009.27

1 reference

Dimensions Publication ID

3 November 2017

0 references

1 reference